Clinical Trials Directory

Trials / Completed

CompletedNCT03622320

Metabolic Syndrome in Early Onset Versus Late Onset Vitiligo

Status
Completed
Phase
Study type
Observational
Enrollment
300 (actual)
Sponsor
Cairo University · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

This study aims at detection of possible associated metabolic syndrome with vitiligo and assessment of possible contribution of the age of onset of vitiligo.

Detailed description

This study aims at detection of incidence of metabolic syndrome in vitiligo patients and possible contribution of the age of onset of the disease. This involves detection of waist circumference, body mass index, index of central obesity, systolic and diastolic arterial blood pressure, fasting blood sugar, high density lipoproteins and triglycerides, in addition to insulin resistance as Homeostatic Model Assessment- insulin resisitance (HOMA-IR) and serum leptin in vitiligo patients. The outcomes will be correlated to extent/ severity/duration/ activity of vitiligo as well as to the age of onset. This is assumed to be of profound impact on vitiligo patients by properly assessing these patients for associated metabolic risk factors and helping prevent such metabolic derangements by detection of possible contributing factors such as insulin resistance and high serum adipokines as leptin. Since there is temporal relation between nutrition, metabolic derangements and skin diseases where nutritional deficiencies as minerals, vitamins and fatty acids can lead to cutaneous manifestations and , on the other hand; skin diseases could contribute to metabolic derangements and nutritional deficiencies, the investigator's study will focus on nutrition and dietary habits and there possible contribution to any associated metabolic risk in vitiligo patients. This is likely to open new horizons in the management of vitiligo, possibly through control of metabolic syndrome risk factors and insulin resistance as well as revealing possible temporal relation to dietary habits that are overlooked in vitiligo patients.

Conditions

Interventions

TypeNameDescription
OTHERBlood sampleBlood sample for fasting blood sugar (FBS), High density lipoproteins (HDL), Triglycerides (TG) ,HOMA-IR, serum leptin

Timeline

Start date
2018-07-01
Primary completion
2019-06-30
Completion
2019-06-30
First posted
2018-08-09
Last updated
2025-04-24

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT03622320. Inclusion in this directory is not an endorsement.